2006

2010

8. juni 2010:Pressemeddelelse nr. 5, 2010: Zealand Pharma Announces An Extension of The Lixisenatide...

Read More >
Meet us

The 31st European Peptide Symposium, Copenhagen, Denmark, 5-9 September 2010 (Science) 46th An...

Read More >

2006

5 September, 2006:
Press release no. 4: Zealand Pharma raises capital for development of drugs for heart and cancer patients

10 April, 2006:
Press release no. 3: Sanofi-Aventis initiates Phase II dose ranging study for the GLP-1 Agonist AVE0010 (ZP10), licensed from Zealand Pharma A/S, in Metformin-treated patients with Type 2 Diabetes

6 March 2006:
Press release no. 2: Zealand Pharma initiates Phase 2 efficacy study in patients with acute decompensated heart failure

22 February 2006:
Press release no. 1, 2006: New members of Zealand Pharma’s Board of Directors

Tip a friend

Fill in the form below to tip a friend about this page.

Subscribe

When this page is updated you will be updated by e-mail.

Related links

Home Legal Disclaimer Updated: 27.7.2010